लोड हो रहा है...
A COMMON ANTI-CMV DRUG, GANCICLOVIR, INHIBITS HIV-1 REPLICATION IN HUMAN TISSUES EX VIVO
Cytomegalovirus (CMV) is a common HIV-1 copathogen. Since CMV infection is an important contributor to immune activation, the driving force of HIV disease, an anti-CMV strategy might be beneficial to HIV-infected patients. Shin et al. reported that anti-CMV therapy with valganciclovir in coinfected...
में बचाया:
| में प्रकाशित: | AIDS |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5541768/ https://ncbi.nlm.nih.gov/pubmed/28657962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001532 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|